Security Name | Ticker | % of Net Assets |
---|---|---|
ABBVIE INC | ABBV | 8.59% |
AMGEN INC. | AMGN | 5.40% |
GILEAD SCIENCES, INC. | GILD | 4.78% |
VERTEX PHARMACEUTICALS | VRTX | 4.24% |
REGENERON PHARMACEUTICALS | REGN | 3.35% |
ALNYLAM PHARMACEUTICALS | ALNY | 3.20% |
CORTEVA INC | CTVA | 2.54% |
INSMED INC | INSM | 2.50% |
ASTRAZENECA PLC ADR | AZN | 2.18% |
BIOGEN IDEC, INC. | BIIB | 2.05% |
BEONE MEDICINES LTD-ADR | BGNE | 1.98% |
NATERA INC | NTRA | 1.90% |
ROYALTY PHARMA PLC- CL A | RPRX | 1.74% |
ILLUMINA INC | ILMN | 1.63% |
INCYTE CORP | INCY | 1.58% |
NEUROCRINE BIOSCIENCES IN | NBIX | 1.49% |
VIATRIS INC | VTRS | 1.45% |
UNITED THERAPEUTICS CORP | UTHR | 1.43% |
JAZZ PHARMACEUTICALS PLC | JAZZ | 1.42% |
IONIS PHARMACEUTICALS, IN | IONS | 1.42% |
ARGENX SE - ADR | ARGX | 1.37% |
MODERNA INC | MRNA | 1.36% |
EXACT SCIENCES | EXAS | 1.35% |
EXELIXIS, INC. | EXEL | 1.34% |
BIOMARIN PHARMACEUTICAL | BMRN | 1.34% |
CRISPR THERAPEUTICS AG | CRSP | 1.29% |
BRIDGEBIO PHARMA INC | BBIO | 1.26% |
GUARDANT HEALTH INC | GH | 1.21% |
ALKERMES PLC | ALKS | 1.20% |
AVIDITY BIOSCIENCES INC | RNA | 1.14% |
ROIVANT SCIENCES LTD | ROIV | 1.14% |
REVOLUTION MEDICINES INC | RVMD | 1.12% |
CYTOKINETICS INC | CYTK | 1.11% |
HALOZYME THERAPEUTICS INC | HALO | 1.10% |
BIONTECH SE-ADR | BNTX | 1.10% |
VAXCYTE INC | PCVX | 1.09% |
TG THERAPEUTICS | TGTX | 1.01% |
ARROWHEAD PHARMACEUTICALS | ARWR | 0.99% |
LEGEND BIOTECH CORP-ADR | LEGN | 0.98% |
PTC THERAPEUTICS | PTCT | 0.96% |
CRINETICS PHARMACEUTICALS | CRNX | 0.91% |
AXSOME THERAPEUT | AXSM | 0.91% |
PROTAGONIST THER | PTGX | 0.86% |
NUVALENT INC-A | NUVL | 0.82% |
VIKING THERAPEUTICS INC | VKTX | 0.81% |
INTELLIA THERAPE | NTLA | 0.80% |
AKERO THERAPEUTICS INC | AKRO | 0.79% |
MEDPACE HOLDINGS | MEDP | 0.76% |
VERACYTE INC | VCYT | 0.73% |
ADMA BIOLOGICS INC | ADMA | 0.73% |
ULTRAGENYX PHARM | RARE | 0.71% |
SUMMIT THERAPEUTICS INC | SMMT | 0.69% |
BEAM THERAPEUTICS INC | BEAM | 0.67% |
IDEAYA BIOSCIENCES INC | IDYA | 0.67% |
SAREPTA THERAPEU | SRPT | 0.67% |
AMICUS THERAPEUTICS INC | FOLD | 0.67% |
APELLIS PHARMACE | APLS | 0.66% |
ACADIA PHARMACEUTICALS IN | ACAD | 0.65% |
ARCELLX INC | ACLX | 0.65% |
RECURSION PHARMACEUTICALS | RXRX | 0.64% |
TWIST BIOSCIENCE CORP | TWST | 0.61% |
AGIOS PHARMACEUT | AGIO | 0.60% |
DENALI THERAPEUT | DNLI | 0.57% |
CELLDEX THERAPEUTICS INC | CLDX | 0.56% |
MADRIGAL PHARMAC | MDGL | 0.54% |
DYNE THERAPEUTICS INC | DYN | 0.54% |
ASCENDIS PHA-ADR | ASND | 0.53% |
NOVAVAX INC | NVAX | 0.53% |
DYNAVAX TECHNOLOGY | DVAX | 0.46% |
IMMUNOVANT INC | IMVT | 0.46% |
SOLENO THERAPEUTICS INC | SLNO | 0.45% |
KRYSTAL BIOTECH INC | KRYS | 0.45% |
IOVANCE BIOTHERAPEUTICS | IOVA | 0.21% |
Other (Cash, derivatives and other liabilities) | 0.36% | |
Total: |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Wealth Solutions, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, GS GAMMA Advisors, LLC, and Guggenheim Private Investments, LLC.
© 2025 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.